Skip to main content

Press Release

2019-12-3

IK Investment Partners acquires Ondal Medical Systems

Category
Press Releases
Share

IK Investment Partners (“IK”) is pleased to announce that the IK VIII Fund has reached an agreement to acquire Ondal Holding GmbH (“Ondal” or “the Company”), a leading Original Design Manufacturer (“ODM”) of medical pendant systems used mainly in operating rooms and intensive care units, from funds advised by Capvis.

Founded in 1945, Ondal has become the global #1 provider of medical pendant systems. With its innovative and broad product portfolio applied in settings such as operating rooms, intensive care units as well as diagnostic and imaging rooms, Ondal sets the global quality standard for medical pendant systems in terms of reliability, functionality and usability. Products manufactured by Ondal are internationally certified in various regulated markets, ensuring compliance with the highest quality standards. Headquartered in Hünfeld, Ondal operates three strategically located manufacturing sites in Germany, the US and China, employing over 500 people.

 “With our high-quality pendant products, we carry, move and supply medical equipment to create optimal working conditions. This has enabled us to establish longstanding relationships with international blue-chip customers. IK is the ideal partner as they have a profound understanding of medical technology end-markets and share our vision for growth. We would like to thank Capvis for its support during our partnership,” said Bernd Fabian, CEO of Ondal.

“Ondal is the globally leading platform for medical pendant systems and trusted strategic partner to medical technology companies. Together with management, we will continue to build on the Company’s strong market position as technology leader in its product segment,” said Anders Petersson, Partner at IK and advisor to the IK VIII Fund.

Ondal represents the IK VIII Fund’s fourth Mid Cap acquisition this year, and the 15th acquisition announced by the Fund. Financial terms of the transaction are not disclosed.

Parties involved:
IK Investment Partners: Anders Petersson, Adrian Tanski, Daniel-Vito Günther
Buyer financial advisor: Quarton (Konstantin Schönborn, Rolf Holtmann)
Buyer strategic due diligence: Alvarez & Marsal (Georg Hochleitner)
Buyer financial due diligence: Eight Advisory (Michael Wahl)
Buyer legal advisor: Renzenbrink & Partner (Ulf Renzenbrink)
Capvis: Eric Trüeb, Leif-Niklas Fanter
Seller financial advisor: William Blair (Philipp Mohr, Eike Dickmann)
Seller legal advisor: Hengeler Müller (Daniel Wiegand)

For further questions, please contact:

IK Investment Partners 
Anders Petersson, Partner 
Phone: +49 40 369 8850

Mikaela Murekian, Director Communications & ESG 
Phone: +44 77 87 573 566 
mikaela.murekian@ikinvest.com

About IK Investment Partners

IK Investment Partners (“IK”) is a Pan-European private equity firm focused on investments in the Nordics, DACH region, France, and Benelux. Since 1989, IK has raised more than €10 billion of capital and invested in over 130 European companies. IK funds support companies with strong underlying potential, partnering with management teams and investors to create robust, well-positioned businesses with excellent long-term prospects. For more information, visit www.ikinvest.com

About Ondal Medical Systems

Ondal is one of the world's leading developer and manufacturer of medical pendant systems that facilitate movement, support loads and supply medical equipment with light, gas or data. For more information, visit www.ondal.de

Recent News

2024-12-20
IK Partners to sell Mecenat to Inflexion
Read More
2024-12-19
Eurobio Scientific: EB Development obtains a significant majority of the capital with 88.9% held at the end of the Reopened Offer to continue its development with NextStage AM and IK Partners
Read More
2024-12-16
IK Partners to acquire majority stake in Dains alongside management
Read More
2024-12-12
Rivean Capital has acquired a majority stake in Acture Group from IK Partners
Read More